Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Baldness is linked to a higher risk of coronary artery disease, but not to its severity.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Higher variability in systolic blood pressure increases long-term mortality risk in coronary artery disease patients.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

A new method accurately measures nine specific hormones in human blood.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Pulmonary artery thrombectomy is safe and effective but not widely used.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.